425 ·Filed Sep 14, 2026

MMED

MiniMed Group, Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed18d 4h ago SEC0001628280-26-061702
Rule 425 M&A communications
Actionable Insight • Neutral

The exchange offer is a procedural step toward full separation; monitor the offer expiration and participation rate for potential near-term selling pressure on MMED as MDT shareholders receive and may sell newly issued shares. No fundamental catalyst here — the stock will trade on standalone business execution.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
MMED ▼ -3.87% at T+5d
NEUTRAL call ✗ call lost -3.87% · α vs SPY -3.98% · entry $21.97 → $21.12
Next anchor: T+20d in 10d
Latest observation: T+9 -12.44% FF3 residual α
Entry anchored
Sep 14, 08:55 AM ET
via 1-min bar
T+1d
+0.18%
call +0.18% · α +0.64%
$22.01
settled 17d ago
T+5d
-3.87%
call -3.87% · α -3.98%
$21.12
settled 11d ago
T+20d
—
call — · α —
—
in 10d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Medtronic formally launched an exchange offer to split off its remaining ~89.86% stake in MiniMed, allowing MDT shareholders to swap their shares for MMED common stock. This is a procedural step advancing MiniMed toward full independence, with no changes to deal terms or new financial projections disclosed. The filing is a routine employee communication about participation mechanics, not a market-moving event.

Key Financial Metrics

Deal Type
other

Key Facts

  • Medtronic launched an exchange offer to split off its remaining ~89.86% equity interest in MiniMed.
  • Medtronic shareholders can voluntarily exchange MDT ordinary shares for newly issued MMED common stock.
  • Upon completion, Medtronic will no longer hold any equity stake in MiniMed, making it a fully independent public company.
  • MiniMed crossed $3 billion in annual revenue and launched MiniMed Flex and MiniMed Go products.
  • The exchange offer is made solely via a prospectus filed with the SEC; no recommendation is made by Medtronic or MiniMed.

Financial Impact

No new financial data disclosed; the exchange offer involves up to 225.4M MMED shares (80.1% of outstanding) per prior S-4 filing, but no updated figures in this filing.

ownership structuredilution

Risk Factors

  • Low participation in the exchange offer could delay full separation.
  • Newly issued MMED shares from the exchange may create near-term selling pressure.
  • Execution risk in operating as a fully independent company post-separation.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001628280-26-061702
Document: 0001628280-26-061702-index-headers.html0001628280-26-061702
Document: 0001628280-26-061702-index.html0001628280-26-061702
Document: 0001628280-26-061702.txt0001628280-26-061702
17 reports for MMED
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for MMED — sortable, filterable
TypeNow
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
MIXED ★ 5/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
NEUTRAL ★ 4/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
425
BULLISH ★ 6/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 14, 2026
18d ago
S-4 / 425
NEUTRAL ★ 6/10
$21.97 $21.12▼ −3.87%▼ −3.98%$19.56 (−10.97%)
Sep 1, 2026
4w ago
8-K
BULLISH ★ 7/10
$22.42 $22.76▲ +1.52%▲ +1.44%$19.56 (−12.76%)
Jul 6, 2026
12w ago
3
NEUTRAL ★ 1/10
$15.37 $15.04▼ −2.15%▼ −2.70%$19.56 (+27.26%)
Jun 29, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$14.88 $15.29▲ +2.76%▲ +1.37%$19.56 (+31.45%)
Showing 10 of 17

US Market Status

Market Open — Closes in 2h 20m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access